HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, H. C. Articles by Farese, R. V. Search for Related Content PubMed PubMed Citation Articles by Chen, H. C. Articles by Farese, R. V., Jr Social Bookmarking                What's this?

Dissociation of Obesity and Impaired Glucose Disposal in Mice Overexpressing Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 in White Adipose Tissue

¹ Gladstone Institute of Cardiovascular Disease, San Francisco, California
² Cardiovascular Research Institute, University of California, San Francisco, California
³ Department of Medicine, University of California, San Francisco, California

Acyl coenzyme A:diacylglycerol acyltransferase 1 (DGAT1) is one of two DGAT enzymes known to catalyze the final step in mammalian triglyceride synthesis. Mice deficient in DGAT1 are resistant to obesity and have enhanced insulin sensitivity. To understand better the relationship between triglyceride synthesis and energy and glucose metabolism, we generated transgenic (aP2-Dgat1) mice in which expression of murine DGAT1 in the white adipose tissue (WAT) was twofold higher than normal. aP2-Dgat1 mice that were fed a regular diet had larger adipocytes and greater total fat pad weight than wild-type (WT) mice. In response to a high-fat diet, aP2-Dgat1 mice became more obese (20% greater body weight after 15 weeks) than WT mice. However, the increase in adiposity in aP2-Dgat1 mice was not associated with impaired glucose disposal, as demonstrated by glucose and insulin tolerance tests. Correlating with this finding, triglyceride deposition in the liver and skeletal muscle, two major target tissues of insulin, was similar in aP2-Dgat1 and WT mice. Thus, DGAT1 overexpression in murine WAT provides a model in which obesity does not impair glucose disposal. Our findings support the lipotoxicity hypothesis that the deposition of triglycerides in insulin-sensitive tissues other than adipocytes causes insulin resistance.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				G. Ranganathan, R. Unal, I. Pokrovskaya, A. Yao-Borengasser, B. Phanavanh, B. Lecka-Czernik, N. Rasouli, and P. A. Kern The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment J. Lipid Res., November 1, 2006; 47(11): 2444 - 2450. [Abstract] [Full Text] [PDF]

				M. Laplante, W. T. Festuccia, G. Soucy, Y. Gelinas, J. Lalonde, J. P. Berger, and Y. Deshaies Mechanisms of the Depot Specificity of Peroxisome Proliferator-Activated Receptor {gamma} Action on Adipose Tissue Metabolism. Diabetes, October 1, 2006; 55(10): 2771 - 2778. [Abstract] [Full Text] [PDF]

				N. Chen, L. Liu, Y. Zhang, H. N. Ginsberg, and Y.-H. Yu Whole-body Insulin Resistance in the Absence of Obesity in FVB Mice With Overexpression of Dgat1 in Adipose Tissue Diabetes, December 1, 2005; 54(12): 3379 - 3386. [Abstract] [Full Text] [PDF]

				H. C. Chen and R. V. Farese Jr Inhibition of Triglyceride Synthesis as a Treatment Strategy for Obesity: Lessons From DGAT1-Deficient Mice Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 482 - 486. [Abstract] [Full Text] [PDF]

				B. D. Roorda, M. K. C. Hesselink, G. Schaart, E. Moonen-Kornips, P. Martinez-Martinez, M. Losen, M. H. De Baets, R. P. Mensink, and P. Schrauwen DGAT1 overexpression in muscle by in vivo DNA electroporation increases intramyocellular lipid content J. Lipid Res., February 1, 2005; 46(2): 230 - 236. [Abstract] [Full Text] [PDF]

				J. A. Villena, B. Viollet, F. Andreelli, A. Kahn, S. Vaulont, and H. S. Sul Induced Adiposity and Adipocyte Hypertrophy in Mice Lacking the AMP-Activated Protein Kinase-{alpha}2 Subunit Diabetes, September 1, 2004; 53(9): 2242 - 2249. [Abstract] [Full Text] [PDF]

				H. C. Chen, M. Rao, M. P. Sajan, M. Standaert, Y. Kanoh, A. Miura, R. V. Farese Jr., and R. V. Farese Role of Adipocyte-Derived Factors in Enhancing Insulin Signaling in Skeletal Muscle and White Adipose Tissue of Mice Lacking Acyl CoA:Diacylglycerol Acyltransferase 1 Diabetes, June 1, 2004; 53(6): 1445 - 1451. [Abstract] [Full Text] [PDF]

				K.-H. Kim, L. Zhao, Y. Moon, C. Kang, and H. S. Sul Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity PNAS, April 27, 2004; 101(17): 6780 - 6785. [Abstract] [Full Text] [PDF]

				S. J. Stone, H. M. Myers, S. M. Watkins, B. E. Brown, K. R. Feingold, P. M. Elias, and R. V. Farese Jr. Lipopenia and Skin Barrier Abnormalities in DGAT2-deficient Mice J. Biol. Chem., March 19, 2004; 279(12): 11767 - 11776. [Abstract] [Full Text] [PDF]